QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PSNL

QT55Personalis, Inc.
NASDAQ·Healthcare·Medical - Diagnostics & Research·USA
Latest market price
10.54
+0.79+8.10%
OverviewShort InterestFilings
PSNLQT55Personalis, Inc.·NASDAQ
OverviewShort InterestFilings
10.54+8.10%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06NTRA+2.19%$231.41IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44
Snapshot
Index-P/E-EPS (ttm)-1.02
Insider Own28.76%
Shs Outstand104.72M
Perf Week11.89%
Market Cap865.84MForward P/E-EPS next Y-0.90Insider Trans0.25%Shs Float-Perf Month49.72%
Enterprise Value831.03MPEG-EPS next Q-Inst Own-Short Float-Perf Quarter46.59%
Income-81475769.00P/S13.42EPS this Y-0.28%Inst Trans-Short Ratio-Perf Half Y32.08%
Sales64.51MP/B3.99EPS next Y12.43%ROA-29.36%Short Interest-Perf YTD32.41%
Book/sh2.44P/C-EPS next 5Y-ROE-43.52%52W High12.53 -15.88%Perf Year69.18%
Cash/sh2.23P/FCF-EPS past 3/5Y-ROIC-34.86%52W Low3.84 174.48%Perf 3Y-
Dividend Est.-EV/EBITDA-9.72Sales past 3/5Y-Gross Margin13.72%Volatility5.97% 6.35%Perf 5Y-
Dividend TTM-EV/Sales12.88EPS Y/Y TTM-Oper. Margin-158.91%ATR (14)0.87Perf 10Y-
Dividend Ex-Date-Quick Ratio6.44Sales Y/Y TTM-25.88%Profit Margin-148.11%RSI (14)62.12Recom2.20
Dividend Gr. 3/5Y-Current Ratio6.61EPS Q/Q-SMA204.49%Beta3.04Target Price11.00
Payout0.00%Debt/Eq0.15Sales Q/Q-28.57%SMA5035.81%Rel Volume1.46Prev Close9.75
Employees228LT Debt/Eq0.12Earnings-SMA20030.86%Avg Volume2.62MPrice10.54
IPO DateJun 20, 2019Option/ShortYes / YesEPS/Sales Surpr.-Net Debt/EBITDA0.41Volume3,820,001Change8.10%
Analyst Ratings
DateActionAnalystRatingTarget
May-12-26ReiteratedMorgan StanleyEqual Weight$11 → $9.00
May-11-26ReiteratedBTIGBuy$6.00 → $11
Jan-26-26ReiteratedGuggenheimBuy$13
Nov-05-25ReiteratedLake StreetBuy$9.00 → $11
Nov-05-25ReiteratedNeedhamBuy$5.50 → $10
Aug-06-25ReiteratedBTIGBuy$8.00 → $6.00
Aug-19-24ReiteratedLake Street$4.00 → $8.00
Aug-19-24ReiteratedH.C. Wainwright$7.50 → $9.00
Aug-16-24ReiteratedBTIGBuy$5.50 → $7.00
Aug-08-24ReiteratedBTIG$5.50
Latest News
Jun-12-26
Jun-12-2607:57AM
Caris Life Sciences: The Discount To Peers Looks Hard To IgnoreSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue63085
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A555458
Gross Profit9-5427
Selling, General and Administrative Excl. Other595446
Research and Development525049
Other Operating Expense0-700
Operating Income-102-88-68
Interest Expense000
Unusual Expense
———
Non-Operating Income (Expense)-8-713
Net Income Before Taxes-96-81-81
Income Taxes
000
Consolidated Net Income-96-81-81
Net Income From Continuing Operations-96-81-81
Net Income-96-81-81
EPS (Recurring)-1.02-0.91-1.37
EPS (Basic, Before Extraordinaries)-1.02-0.91-1.37
EPS (Diluted)-1.02-0.91-1.37
EBITDA-85-71-70
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
17.40——
Gross Margin14.29—31.76
Operating Margin-161.90—-80.00
Net Margin-152.38—-95.29
Shares Outstanding1048959
Market Capitalization1,096708—
Operating Lease Expense
———
Insider Trading Volume
$11.54$10.45$9.37$8.28$7.19● Close Price0.00M0.44M0.87M1.31M1.74MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Tachibana AaronCFO AND COOJun 04 '26Option Exercise9.1680,000732,800238,833Jun 05 12:00 AM
Tachibana AaronCFO AND COOJun 04 '26Sale12.0140,000480,400198,833Jun 05 12:00 AM
Hall Christopher MChief Executive OfficerMay 29 '26Option Exercise1.61160,182257,894316,077May 29 12:00 AM
Tachibana AaronCFO AND COOMay 29 '26Sale11.5838,799449,292198,833May 29 12:00 AM
Tachibana AaronCFO AND COOMay 29 '26Option Exercise9.1677,598710,798237,632May 29 12:00 AM
Hall Christopher MChief Executive OfficerMay 29 '26Sale11.0280,091882,603235,986May 29 12:00 AM
Hall Christopher MChief Executive OfficerMay 28 '26Option Exercise1.6139,81864,106380,091May 29 12:00 AM
Tempus AI, Inc.10% OwnerDec 22 '25Buy8.9328,000250,04013,039,067Feb 13 12:00 AM
Tempus AI, Inc.10% OwnerDec 19 '25Buy8.3929,641248,68813,011,067Feb 13 12:00 AM
Tempus AI, Inc.10% OwnerDec 18 '25Buy7.9131,430248,61112,981,426Feb 13 12:00 AM
Tempus AI, Inc.10% OwnerDec 17 '25Buy7.8631,650248,76912,949,996Feb 13 12:00 AM
Tempus AI, Inc.10% OwnerNov 25 '25Buy10.6223,600250,66512,918,346Feb 13 12:00 AM
Tempus AI, Inc.10% OwnerNov 24 '25Buy9.8725,225248,97112,894,746Feb 13 12:00 AM
Tempus AI, Inc.10% OwnerNov 21 '25Buy9.4026,499249,19012,869,521Feb 13 12:00 AM
Tempus AI, Inc.10% OwnerNov 20 '25Buy8.6328,827248,77712,843,022Feb 13 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR